Project Grant R21MH137564
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Pittsburgh a $185,552 Project Grant effective September 19, 2025, under the Mental Health Research Grants program (CFDA 93.242) to investigate neurocognitive responses to social threat and their connection to suicidality in adolescent girls. The research will generate scientific knowledge through a K23 mentored research career development award examining how sustained neural responsivity to...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Pittsburgh a Project Grant totaling $378,984 under the Mental Health Research Grants program (CFDA 93.242), with an award date of March 13, 2026 and completion date of February 28, 2031. This K23 mentored research grant supports a novel neurobiological investigation examining the relationship between peripheral inflammatory markers and reward-related neural circuitry dysfunction in adolescents...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Pittsburgh a $782,547 Project Grant on August 19, 2025, under the Mental Health Research Grants program (CFDA 93.242) to investigate the role of puberty in corticostriatal circuitry development and avoidance behavior in adolescents with anxiety disorders. The research will extend through July 31, 2030, and focuses on understanding how pubertal hormones impact reward processing and learning...
- Federal Grant Award Summary The University of Pittsburgh received a $190,188 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded June 3, 2026, with a completion date of May 31, 2031. This five-year research initiative investigates the neural substrates of perseverative thought disengagement and reward learning in early adolescent girls, with particular focus on how puberty influences these cognitive-affective...
- Federal Grant Award Summary The National Institute of Mental Health awarded the University of Pittsburgh a $792,006 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to conduct a longitudinal study examining suicidality in autistic adults. Commencing September 1, 2025, and concluding June 30, 2030, this research initiative will enroll 250 autistic adults (ages 18-40), with at least half representing high-risk individuals with active suicidal ideation or suicidal...
- Grant Award Summary The National Institute of Mental Health awarded a Project Grant of $1,353,162 to the University of Pittsburgh (with a sub-award to the University of California, Los Angeles) under the Mental Health Research Grants program (CFDA 93.242). The award, issued July 15, 2025, with completion targeted for April 30, 2030, funds research investigating the mechanisms linking early life adversity—including maltreatment and exposure to neighborhood violence—to increased depression risk in...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Research Foundation For Mental Hygiene, Inc., a $868,015 Project Grant on June 12, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and implement the SAFER (Suicide Assessment and Follow-up After Emergency Department Release) initiative. This research project, which extends through February 28, 2031, addresses the critical public health concern of suicide among children aged 8-12...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Illinois a Project Grant totaling $100,228 under the Mental Health Research Grants program (CFDA 93.242) to implement suicide prevention strategies in outpatient pediatric behavioral health settings. The project, which commenced on September 30, 2026, and concludes on May 31, 2028, will deliver qualitative research findings and contextually tailored implementation strategies designed to...
- Summary of Federal Project Grant Award The National Institute of Mental Health (NIMH) awarded the University of Pittsburgh a Project Grant totaling $1,004,971 under the Mental Health Research Grants program (CFDA 93.242) for the period April 8, 2026 through February 28, 2029. The grant supports development of an integrated research platform designed to measure and analyze the dynamic interrelationship between brain activity, cognitive states, behavior, and physiological responses over...
- Federal Grant Award Summary The University of Pittsburgh received a $437,250 Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242) for the period April 1, 2026 through March 31, 2028. This exploratory R21 award supports research investigating parvalbumin interneuron (PVI) diversity and plasticity in primary visual and prefrontal cortical areas, with emphasis on understanding how these inhibitory neurons contribute to...
The National Institute of Mental Health (NIMH) awarded the University of Pittsburgh a $437,250 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to conduct a longitudinal feasibility study examining the association between childhood gender nonconformity (GNC) and early indicators of risk for suicidal behavior. The award, obligated on June 5, 2026, with a completion date of May 31, 2028, will generate research data and findings addressing a critical gap in the literature on suicide prevention among youth. The study will enroll children ages 7-10 enriched for GNC and collect comprehensive data on psychosocial stressors, biological dysregulation (particularly in the hypothalamic-pituitary-adrenal axis and inflammatory pathways), psychiatric diagnoses and symptoms, neurocognitive correlates of suicidal risk, and suicidal ideation. This feasibility study will establish whether GNC represents a valuable early developmental indicator for identifying children at elevated future risk for suicidal behavior. The research will produce peer-reviewed publications, datasets, and mechanistic insights into how early psychosocial stressors and biological dysregulation associated with GNC may contribute to psychiatric symptoms and increased suicide risk during adolescence. By identifying earlier developmental risk markers through rigorous longitudinal investigation, the study aims to support the development of evidence-based prevention and intervention strategies to reduce suicide—a leading cause of death among adolescents—and advance the NIMH mission of transforming the understanding and treatment of mental illness through research.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $437.3k | 6/8/26 |